Navigation Links
Lung airway cells activate vitamin D and increase immune response
Date:11/3/2008

Vitamin D is essential to good health but needs to be activated to function properly in the human body. Until recently, this activation was thought to happen primarily in the kidneys, but a new University of Iowa study finds that the activation step can also occur in lung airway cells.

The study also links the vitamin D locally produced in the lung airway cells to activation of two genes that help fight infection. The study results appear in the Nov. 15 issue of the Journal of Immunology, now online.

In addition to contributing to calcium absorption and bone health, vitamin D is increasingly recognized for its beneficial effects on the immune system. Vitamin D deficiency has been recently linked to increased risk of some infections, autoimmune diseases such as multiple sclerosis and type 1 diabetes, and some cancers.

"The more scientists have been studying vitamin D, the more we learn about new roles it plays in the human body," said the study's lead author Sif Hansdottir, M.D., fellow in internal medicine in the University of Iowa Carver College of Medicine. "The active form of vitamin D is known to affect the expression of more than 200 genes, so we were interested both in the possible lung-specific production of active vitamin D and in vitamin D-dependent production of proteins that fight infections."

The first step in vitamin D activation takes place in the liver, where an enzyme called 25-hydroxylase converts vitamin D into a "storage" form. The next step takes place typically in the kidneys, but in recent years, tissue and organs such as skin, intestines, breast and prostate have been found also to express the enzyme that completes vitamin D conversion.

The University of Iowa team, based in the laboratory of Gary Hunninghake, M.D., professor of internal medicine and the study's senior author, used cells from deceased human donors to demonstrate that the presence of the enzyme 1 alpha-hydroxylase in
'/>"/>

Contact: Becky Soglin
becky-soglin@uiowa.edu
319-335-6660
University of Iowa
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Franklin Square to study airway bypass procedure for severe emphysema
2. Researchers at Sarasota Memorial Health Care System to study airway bypass treatment for emphysema
3. Positive results for airway bypass
4. New method provides panoramic view of protein-RNA interactions in living cells
5. Simple chemical procedure augments therapeutic potential of stem cells
6. Researchers at UH explore use of fat cells as heart attack therapy
7. Mediator in communication between neurons and muscle cells found
8. JDRF to provide $1M in funding to SmartCells, Inc.
9. Seemingly suicidal stunt is normal rite of passage for immune cells
10. Swamping bad cells with good in ALS animal models helps sustain breathing
11. Forsyth scientists trigger cancer-like response from embryonic stem cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... Calif., Oct. 19 Spectros, develop...and imaging devices which shed light on life-threa...d exclusive distribution deals for both its T-Stat...ts covered include Australia, New Zealand, The Ne..., Italy, France, Spain, Portugal, Poland, Greece, ...
(Date:11/4/2009)... Oct. 20 Aware, Inc. (Na...hnology and biometrics software, today reported fi...mber 30, 2009. ,, Michael Tzannes, Aware,s Ch... today, we announced an agreement to sell our DSL ... fabless semiconductor company being spun out of I...
(Date:11/4/2009).... 26 BIO-key Internation...inger-based biometric identification software is s...the AABB TXPO conference being held at the New Orl...O-key will provide hands-on product demonstrations... in booth #424. Also, at 5 PM on Monday, October 2...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2In Health Care Today Its Electronic All the Way 58815 1In Health Care Today Its Electronic All the Way 58815 2In Health Care Today Its Electronic All the Way 58815 3Park Meadows Cosmetic Surgery a Leader in Breast Reconstruction Surgery Recognizes National Breast Cancer Awareness Month 58813 1Park Meadows Cosmetic Surgery a Leader in Breast Reconstruction Surgery Recognizes National Breast Cancer Awareness Month 58813 2Park Meadows Cosmetic Surgery a Leader in Breast Reconstruction Surgery Recognizes National Breast Cancer Awareness Month 58813 331 Breast Cancer Myths 26amp 3B Truths in 31 Days 58811 131 Breast Cancer Myths 26amp 3B Truths in 31 Days 58811 2
...release is available in French . Montreal, 13...ealth Centre (MUHC), McGill University and the Uni...medical use of cannabinoids do not cause an increa...ith an increase in some non-serious adverse events...rom the cannabis plant, or cannibinoids, are avail...
...towers Institute,s Rong Li Lab has discovered that...ammation may also have a role in the formation of ...ase (ADPKD) one of the most common life-threateni...ibiting the protein can slow the disease in mice. ...nline publication of Nature Medicine yesterday. ...
...ANCISCO, CA June 16, 2008 --- iZumi Bio, Inc. and... non-profit biomedical research organization, have...nsing agreement to focus on applications for induc... "reprogrammed" adult cells that have similar prop...tem (ES) cells, yet do not raise the same ethical ...
Other Biology News:Medicines derived from cannabis: a review of adverse events 2Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment 2
(Date:11/6/2009)... , The agenda for Arrowhe... Conference, which is set to take place on Februar... At this three day conference we will highlight ke...st speakers to share their experiences. , ...6, 2009 -- The agenda for Arrowhead’s 2010 ...
(Date:11/5/2009)... , PARSIPPANY, N.J., Nov. 5 D... has made a manufacturing alliance with Galenix, S...referred commercial scale manufacturing partner fo..., DSM and Galenix will collaborate on business ...g delivery technologies, based on the strength of ...
(Date:11/5/2009)... , OMAHA, Neb., Nov. 5 /PRNewswire-FirstCall/...today announced financial results for the quarter ...results are presented in the tables that follow. ,...ed a net loss of $366,000 or $0.01 per share for t... of $499,000 or $0.01 per share for the third quar...
(Date:11/5/2009)... , SAN DIEGO, CA, November 5, 2009 /PRNewswir...company focused on using proprietary taste recepto...edients for the food, beverage, and ingredient sup...and reported financial results for the third quart...illion for the third quarter of 2009, compared to ...
Breaking Biology Technology:Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14
...cology clinical development solutions in North Ame...il 17 SIRO ClinPharm (SIRO), a leading multinat...announced the signing of a strategic alliance with...ons), Flemington, NJ, USA, a service provider in o...tion in North America. This alliance will enable ...
...v, a global chemistry-driven contract research org...ech Center has acquired Prudentas LLC, one of the ...e I - Phase IV studies in Eastern Europe. Prudenta...siness name Prudentas LLC, a ChemDiv Group compan...ed with Prudentas, who established itself as an ex...
...electronic information from old cassette tapes to... the electronics industry for decades. , Low-powe...long-term result of collaborative research led by ...search, to be published April 17 in the journal S...l-known oxide, strontium titanate, and depositing ...
Other Biology Technology:SIRO ClinPharm and Advanced Clinical Trial Solutions Ink Strategic Alliance 2ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center 2ChemDiv Group Acquires Prudentas Through ChemRar High Tech Center 3Putting the squeeze on an old material could lead to 'instant on' electronic memory 2
... is used to quantitate double-stranded DNA (dsDNA)...in. With this kit, DNA is stained with Hoechst 332... other fluorometer. The kit quantitates dsDNA in t...d contains Hoechst 33258, calf thymus DNA standard...
...rise-scale sequence analysis software with the DeC...tensive bioinformatics analyses. With DeCypher, yo...p: BLAST 300,000 ESTs vs NCBI NT database in unde...nomic DNA Use HMM analysis to compare 100,000 se...
MagNA Pure LC Instrument from Roche Applied Science
Mouse Anti-Human ALS2CR8 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: